Obesity and related metabolic conditions program(HAYA)

N/A

Report date: 2025/09/05 13:27:29
NME

Base Information

Drug NameObesity and related metabolic conditions program(HAYA)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsObesityMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHAYA Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesHAYA Therapeutics SAEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A